Skip to content
Investor Centre
Portal Access
Careers
Distributors
Australia
USA
EMEA
Log In
About Us
About Us
Genetic Signatures is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Company Background
Our Technology
Our Facilities
Intellectual Property
Our Board
Our Principal Advisors
Our Management Team
Our Products
Our Products
Genetic Signatures is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
All Products
Gastrointestinal Infections
Bacterial Pathogen detection
Parasite Pathogen Detection
Viral Pathogen Detection
Respiratory
Respiratory Pathogen Detection
Atypical Pathogen Detection
Coronavirus Detection
SARS-CoV-2 Detection
Sexual Health
Sexually Transmitted Infections
Anti-Microbial Resistance
ESBL/CPO Screening
Meningitis
Viral Meningitis
Tropical Disease
Flavivirus & Alphavirus Screening
Product Pipeline
Workflow
Media Centre
Media Centre
Genetic Signatures is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
All media
Blog
News
Events
Videos
Webinar
Publications, Articles & Presentations
Resources
Contact Us
Search
Search
Semi-Quantitative, Duplexed qPCR Assay for the Detection of Leishmania spp. Using Bisulphite Conversion Technology.
Download our poster here
.
Posts navigation
← Genetic Signatures’ CEO, John Melki, talks with Nadine Blayney from AusBiz
ASTMH 2022 →
×
